4//SEC Filing
Lee Jennifer Kayden 4
Accession 0001104659-25-010610
CIK 0001649904other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:05 PM ET
Size
9.2 KB
Accession
0001104659-25-010610
Insider Transaction Report
Form 4
Lee Jennifer Kayden
EVP, Head of North America
Transactions
- Sale
Common Stock
2025-02-05$60.08/sh−1,733$104,121→ 2,305 total - Sale
Common Stock
2025-02-05$61.95/sh−200$12,390→ 972 total - Sale
Common Stock
2025-02-05$61.01/sh−1,133$69,130→ 1,172 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $59.54 to $60.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $60.67 to $61.49. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001801372
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 5:05 PM ET
- Size
- 9.2 KB